首页 > 最新文献

L'union medicale du Canada最新文献

英文 中文
[Focus on smoking]. [关注吸烟]。
Pub Date : 1994-01-01
M Gagné, A Gervais, M Juneau, R Laforte, C Lemoine, G Ostiguy, D Perreault, M Robitaille, J Taillefer, M Xhignesse
{"title":"[Focus on smoking].","authors":"M Gagné, A Gervais, M Juneau, R Laforte, C Lemoine, G Ostiguy, D Perreault, M Robitaille, J Taillefer, M Xhignesse","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19100751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The skeleton: a true bazaar!]. 骷髅:一个真正的集市!
Pub Date : 1994-01-01
R Henry
{"title":"[The skeleton: a true bazaar!].","authors":"R Henry","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19100750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Initial empiric treatment of pneumonia and the new antibiotics]. [肺炎的初步经验性治疗及新型抗生素]。
Pub Date : 1994-01-01
M Parent
{"title":"[Initial empiric treatment of pneumonia and the new antibiotics].","authors":"M Parent","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19100745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Update on inhalation therapy in asthma and obstructive bronchopulmonary diseases]. [哮喘和阻塞性支气管肺疾病吸入疗法的最新进展]。
Pub Date : 1994-01-01
L P Boulet, P d'Amours, D Bérubé, M Rouleau, J G Parent, C Pelletier, C Touchette

Significant changes have occurred in aerosol therapy in the last few years. New devices have been developed to facilitate the administration of bronchodilator or anti-inflammatory drugs into the airways. Metered-dose inhaler with or without a spacer or powder devices are now considered the ideal mode of administration of aerosolized medications in the regular treatment of child or adult asthma as well as in COPD. In mild to moderate acute asthma, bronchodilators are ideally administered with a metered dose inhaler with a spacer device, nebulisation being required in only a minority of patients. Powder devices such as the Turbuhaler may also be useful in acute asthma but inspiratory flow should be sufficient, and their usefulness in this context remains to be better determined. In severe acute asthma or in patients unable to properly use the other inhalation devices, nebulisation can be used, with oxygen in the case of acute asthma. In patients requiring mechanical ventilation, administration of bronchodilators can be done with a metered-dose inhaler with a spacer device specifically designed for this purpose: it will replace nebulisation in most cases. In young children and infants unable to use spacer devices with a mouthpiece (< 5 years), wet nebulisation is still used during acute attacks of asthma. In these circumstances, the use of metered-dose inhalers with a spacer and mask are probably appropriate in some children but further studies are required to recommend their use.

在过去几年中,气雾疗法发生了重大变化。已经开发出新的设备,以方便支气管扩张剂或抗炎药物进入气道。带或不带间隔器或粉末装置的计量吸入器现在被认为是儿童或成人哮喘以及慢性阻塞性肺病常规治疗中雾化药物施用的理想模式。在轻度至中度急性哮喘中,理想情况下,支气管扩张剂与带间隔装置的计量吸入器一起使用,只有少数患者需要雾化。粉状装置如Turbuhaler也可能对急性哮喘有用,但吸入流量应该足够,它们在这种情况下的用途仍有待更好地确定。在严重急性哮喘或不能正确使用其他吸入装置的患者中,可以使用雾化,在急性哮喘的情况下使用氧气。在需要机械通气的患者中,支气管扩张剂的给药可以用带有专门为此目的设计的间隔装置的计量吸入器来完成:在大多数情况下,它将取代雾化。对于不能使用带吸口的间隔装置的幼儿和婴儿(小于5岁),在急性哮喘发作期间仍使用湿雾化。在这些情况下,对一些儿童使用带间隔器和口罩的计量吸入器可能是适当的,但需要进一步的研究来推荐它们的使用。
{"title":"[Update on inhalation therapy in asthma and obstructive bronchopulmonary diseases].","authors":"L P Boulet,&nbsp;P d'Amours,&nbsp;D Bérubé,&nbsp;M Rouleau,&nbsp;J G Parent,&nbsp;C Pelletier,&nbsp;C Touchette","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Significant changes have occurred in aerosol therapy in the last few years. New devices have been developed to facilitate the administration of bronchodilator or anti-inflammatory drugs into the airways. Metered-dose inhaler with or without a spacer or powder devices are now considered the ideal mode of administration of aerosolized medications in the regular treatment of child or adult asthma as well as in COPD. In mild to moderate acute asthma, bronchodilators are ideally administered with a metered dose inhaler with a spacer device, nebulisation being required in only a minority of patients. Powder devices such as the Turbuhaler may also be useful in acute asthma but inspiratory flow should be sufficient, and their usefulness in this context remains to be better determined. In severe acute asthma or in patients unable to properly use the other inhalation devices, nebulisation can be used, with oxygen in the case of acute asthma. In patients requiring mechanical ventilation, administration of bronchodilators can be done with a metered-dose inhaler with a spacer device specifically designed for this purpose: it will replace nebulisation in most cases. In young children and infants unable to use spacer devices with a mouthpiece (< 5 years), wet nebulisation is still used during acute attacks of asthma. In these circumstances, the use of metered-dose inhalers with a spacer and mask are probably appropriate in some children but further studies are required to recommend their use.</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19100747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[From Lorenzo's oil to myelin]. [从洛伦佐的油到髓磷脂]。
Pub Date : 1994-01-01
A Merminod, B Lemieux
{"title":"[From Lorenzo's oil to myelin].","authors":"A Merminod,&nbsp;B Lemieux","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19100749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The treatment of acromegaly]. 肢端肥大症的治疗。
Pub Date : 1993-11-01
H Beauregard, M Somma, E Rasio, O Serri, N Aris-Jilwan, R Comtois, H Long, T Abribat, A Boucher, J Hardy

Acromegaly is a rare disease which can significantly reduce life expectancy. Clinical features are diverse and the patient may consult a variety of medical and surgical specialists before the diagnosis is suspected. However, the disease is easily confirmed by the appropriate laboratory tests, namely GH and IGF1 measurements. In most cases, acromegaly is secondary to a micro or macrosomatotrope pituitary adenoma. Those lesions are easily visualized by a pituitary CT Scan or Magnetic Resonance Imaging. Visual fields have to be evaluated by a neuro-ophthalmologist, and a thorough evaluation of other pituitary functions have to be performed. Selective removal of the adenoma by the transsphenoidal route is the treatment of choice for acromegaly. When performed by an experienced neurosurgeon, normalization of GH secretion can be expected in approximately 75% of cases. The surgical outcome is modulated by the volume, the extension of the tumor and the preoperative GH level. Octreotide, radiotherapy or bromocriptine are indicated whenever the patient remains with an elevated level of GH with persistency of symptoms.

肢端肥大症是一种罕见的疾病,可以显著降低预期寿命。临床特征是多种多样的,在怀疑诊断之前,患者可能会咨询各种内科和外科专家。然而,这种疾病很容易通过适当的实验室检查,即生长激素和IGF1的测量来确诊。在大多数情况下,肢端肥大症继发于微小或巨大生长斜变性垂体腺瘤。这些病变很容易通过垂体CT扫描或磁共振成像发现。视野必须由神经眼科医生评估,并对垂体的其他功能进行全面评估。经蝶窦途径选择性切除腺瘤是肢端肥大症的治疗选择。当由经验丰富的神经外科医生进行手术时,大约75%的病例可以预期生长激素分泌正常化。手术结果是由体积、肿瘤的扩展和术前GH水平调节的。当患者生长激素水平持续升高且症状持续时,应采用奥曲肽、放疗或溴隐亭。
{"title":"[The treatment of acromegaly].","authors":"H Beauregard,&nbsp;M Somma,&nbsp;E Rasio,&nbsp;O Serri,&nbsp;N Aris-Jilwan,&nbsp;R Comtois,&nbsp;H Long,&nbsp;T Abribat,&nbsp;A Boucher,&nbsp;J Hardy","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Acromegaly is a rare disease which can significantly reduce life expectancy. Clinical features are diverse and the patient may consult a variety of medical and surgical specialists before the diagnosis is suspected. However, the disease is easily confirmed by the appropriate laboratory tests, namely GH and IGF1 measurements. In most cases, acromegaly is secondary to a micro or macrosomatotrope pituitary adenoma. Those lesions are easily visualized by a pituitary CT Scan or Magnetic Resonance Imaging. Visual fields have to be evaluated by a neuro-ophthalmologist, and a thorough evaluation of other pituitary functions have to be performed. Selective removal of the adenoma by the transsphenoidal route is the treatment of choice for acromegaly. When performed by an experienced neurosurgeon, normalization of GH secretion can be expected in approximately 75% of cases. The surgical outcome is modulated by the volume, the extension of the tumor and the preoperative GH level. Octreotide, radiotherapy or bromocriptine are indicated whenever the patient remains with an elevated level of GH with persistency of symptoms.</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19291903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research in psychiatry]. [精神病学研究]。
Pub Date : 1993-11-01
Y Lamontagne, A Lesage

The department of psychiatry of the Université de Montréal has now organized a well structured research network in the area of child, adult and forensic psychiatry. The authors summarize the scientific approach according to research in these different sectors and believe that, although research in psychiatry now tends to promote diagnostic and treatment methods based more and more on neuro-sciences, it does not neglect the contribution of psychosocial and clinical aspects without which the human dimensions of mental illness and the objective of improvement of care to patients would be rapidly forgotten on behalf of disembodied research projects completely deprived of the relation with patients.

蒙特兰萨塔尔大学精神病学系现已在儿童、成人和法医精神病学领域组织了一个结构良好的研究网络。作者根据这些不同领域的研究总结了科学方法,并认为,尽管精神病学研究现在倾向于促进越来越多基于神经科学的诊断和治疗方法,它没有忽视社会心理和临床方面的贡献,没有这些方面,精神疾病的人类层面和改善对病人护理的目标将很快被遗忘,因为没有实体的研究项目完全剥夺了与病人的关系。
{"title":"[Research in psychiatry].","authors":"Y Lamontagne,&nbsp;A Lesage","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The department of psychiatry of the Université de Montréal has now organized a well structured research network in the area of child, adult and forensic psychiatry. The authors summarize the scientific approach according to research in these different sectors and believe that, although research in psychiatry now tends to promote diagnostic and treatment methods based more and more on neuro-sciences, it does not neglect the contribution of psychosocial and clinical aspects without which the human dimensions of mental illness and the objective of improvement of care to patients would be rapidly forgotten on behalf of disembodied research projects completely deprived of the relation with patients.</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19291935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[New treatment strategies in coronary disease]. [冠心病的新治疗策略]。
Pub Date : 1993-11-01
M G Bourassa

The mortality associated with coronary atherosclerosis has decreased by 30% to 40% in the last few decades. This reduction has followed major pharmacological and biotechnological advances and can possibly be attributed to better management of risk factors for coronary atherosclerosis and to more effective therapy of its late manifestations. Nevertheless, the coronary artery disease remains a major public health problem. It is responsible for 40% to 45% of deaths in our population and, although it becomes manifest later than previously, its incidence and prevalence may not have declined significantly. Recent studies suggest that progression of coronary atherosclerosis can be delayed, that regression can also occur, and that this can lead to a reduction in morbidity and mortality. Several types of interventions have been performed in these studies. Some of them such as a drastic modification in lifestyle, the administration of one or several hypocholesterolemic agents or partial ileal bypass have achieved these results by markedly lowering LDL or raising HDL cholesterol. Other manipulations of plasma lipoproteins are also possible, such as the administration of specific protein or enzyme inhibitors, anti-oxidants and omega-3 fatty acids. Calcium antagonists and possibly angiotensin converting-enzyme inhibitors slow the progression of early coronary lesions and prevent the appearance of new lesions. These interventions, in addition to influencing the size of the atherosclerotic plaque, can have other important effects. They can contribute to the preservation of integrity and function of endothelial cells.(ABSTRACT TRUNCATED AT 250 WORDS)

在过去的几十年里,与冠状动脉粥样硬化相关的死亡率下降了30%到40%。这种减少是由于主要的药理学和生物技术的进步,可能归因于更好地管理冠状动脉粥样硬化的危险因素和更有效的治疗其晚期表现。然而,冠状动脉疾病仍然是一个主要的公共卫生问题。我国人口中40%至45%的死亡是由该病造成的,尽管该病比以前更晚出现,但其发病率和流行率可能没有显著下降。最近的研究表明,冠状动脉粥样硬化的进展可以延迟,也可以发生倒退,这可以导致发病率和死亡率的降低。在这些研究中进行了几种类型的干预。其中一些方法,如生活方式的剧烈改变,使用一种或几种降胆固醇药物或部分回肠旁路治疗,通过显著降低低密度脂蛋白或提高高密度脂蛋白胆固醇来达到这些效果。对血浆脂蛋白的其他操作也是可能的,例如使用特定的蛋白质或酶抑制剂、抗氧化剂和omega-3脂肪酸。钙拮抗剂和可能的血管紧张素转换酶抑制剂减缓早期冠状动脉病变的进展并防止新病变的出现。这些干预措施,除了影响动脉粥样硬化斑块的大小外,还有其他重要作用。它们有助于保持内皮细胞的完整性和功能。(摘要删节250字)
{"title":"[New treatment strategies in coronary disease].","authors":"M G Bourassa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The mortality associated with coronary atherosclerosis has decreased by 30% to 40% in the last few decades. This reduction has followed major pharmacological and biotechnological advances and can possibly be attributed to better management of risk factors for coronary atherosclerosis and to more effective therapy of its late manifestations. Nevertheless, the coronary artery disease remains a major public health problem. It is responsible for 40% to 45% of deaths in our population and, although it becomes manifest later than previously, its incidence and prevalence may not have declined significantly. Recent studies suggest that progression of coronary atherosclerosis can be delayed, that regression can also occur, and that this can lead to a reduction in morbidity and mortality. Several types of interventions have been performed in these studies. Some of them such as a drastic modification in lifestyle, the administration of one or several hypocholesterolemic agents or partial ileal bypass have achieved these results by markedly lowering LDL or raising HDL cholesterol. Other manipulations of plasma lipoproteins are also possible, such as the administration of specific protein or enzyme inhibitors, anti-oxidants and omega-3 fatty acids. Calcium antagonists and possibly angiotensin converting-enzyme inhibitors slow the progression of early coronary lesions and prevent the appearance of new lesions. These interventions, in addition to influencing the size of the atherosclerotic plaque, can have other important effects. They can contribute to the preservation of integrity and function of endothelial cells.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19291895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Renal transplantations: current reality and future challenges]. [肾移植:当前的现实和未来的挑战]。
Pub Date : 1993-11-01
G St-Louis

Kidney transplantation is a well recognized form of treatment for end-stage renal failure patients. Transplanted patients can hope for a prolonged and productive life. Many factors are responsible for the improvement of kidney transplantation over the last years. Despite its progress and success, many limitations still exist: shortage of kidney, humoral hypersensitivity or recipients, side effects of immunosuppressive medication and chronic rejection. Will the induction of specific tolerance to xenograft, with the help of transgenic biology, be the solution of tomorrow?

肾移植是一种公认的治疗终末期肾衰竭的方法。移植的患者可以希望延长和充实的生活。在过去的几年中,许多因素导致了肾移植的改善。尽管它取得了进展和成功,但仍然存在许多局限性:肾脏短缺,体液过敏或受体,免疫抑制药物的副作用和慢性排斥反应。在转基因生物学的帮助下,诱导对异种移植物的特异性耐受性会成为明天的解决方案吗?
{"title":"[Renal transplantations: current reality and future challenges].","authors":"G St-Louis","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Kidney transplantation is a well recognized form of treatment for end-stage renal failure patients. Transplanted patients can hope for a prolonged and productive life. Many factors are responsible for the improvement of kidney transplantation over the last years. Despite its progress and success, many limitations still exist: shortage of kidney, humoral hypersensitivity or recipients, side effects of immunosuppressive medication and chronic rejection. Will the induction of specific tolerance to xenograft, with the help of transgenic biology, be the solution of tomorrow?</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19291897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chemoprevention of lung cancer]. 肺癌的化学预防。
Pub Date : 1993-11-01
J Ayoub, Y Ying, W E Bradley

Chemoprevention, or pharmacological intervention in healthy individuals at risk of developing cancer, is attracting attention as a potential tool in cancer prevention. Lung cancer, with its high incidence and poor prognosis, is a particularly interesting disease for these studies. The retinoids are a promising group of chemopreventive agents, since they are involved in growth control and are a necessary cofactor for proper activity of a protein receptor which we have shown to be a lung cancer suppressor. Nevertheless, the toxic side effects of retinoids at pharmacological dose present difficulties and current studies are aimed at determining the efficacy of various forms of retinoids and chemoprevention protocols in the target populations.

化学预防,或对有患癌症风险的健康个体进行药物干预,作为一种潜在的癌症预防工具正引起人们的关注。肺癌发病率高,预后差,是这些研究特别感兴趣的疾病。类维生素a是一种很有前途的化学预防药物,因为它们参与生长控制,是一种蛋白质受体适当活性的必要辅助因子,我们已经证明这种蛋白质受体是一种肺癌抑制因子。然而,在药理学剂量下类维生素a的毒副作用存在困难,目前的研究旨在确定各种形式的类维生素a和化学预防方案在目标人群中的功效。
{"title":"[Chemoprevention of lung cancer].","authors":"J Ayoub,&nbsp;Y Ying,&nbsp;W E Bradley","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Chemoprevention, or pharmacological intervention in healthy individuals at risk of developing cancer, is attracting attention as a potential tool in cancer prevention. Lung cancer, with its high incidence and poor prognosis, is a particularly interesting disease for these studies. The retinoids are a promising group of chemopreventive agents, since they are involved in growth control and are a necessary cofactor for proper activity of a protein receptor which we have shown to be a lung cancer suppressor. Nevertheless, the toxic side effects of retinoids at pharmacological dose present difficulties and current studies are aimed at determining the efficacy of various forms of retinoids and chemoprevention protocols in the target populations.</p>","PeriodicalId":18049,"journal":{"name":"L'union medicale du Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19291940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
L'union medicale du Canada
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1